🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

BioLife Solutions, Inc.

BLFS Healthcare
$37.22 +$0.03 (0.08%)
Market Cap: $1.82 B
Gurus Holding
4
Popularity Rank
#2303
% of Shares Held
1.69%
Net Activity (Q2 2026)
+$2.95 M

Guru Ownership Trend

Guru Analysis for BioLife Solutions, Inc. (BLFS)

BioLife Solutions, Inc. (BLFS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $30.84 M.

Top institutional holders include Chuck Royce and Diamond Hill Capital.

Institutional sentiment is currently Bullish. This is evidenced by a $2.95 M net inflow during the quarter.

Recent activity highlights Diamond Hill Capital who opened a new position.

Key Holders

Top 5 by Value

$17.62 M
$988,937
$444,469

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$6.9 M
Total Buy Value
New Buys 3
Additions 1
-$3.95 M
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for BioLife Solutions, Inc. (BLFS)

Major holders include Chuck Royce ($17.62 M), Diamond Hill Capital ($4.35 M), Steven Cohen ($988,937). According to the latest reported data, 4 tracked investment managers collectively hold approximately 828,520 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.95 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited BLFS. The total reported sell value was $3.95 M.

Yes, 3 managers opened new positions in BLFS, and 1 increased their existing holdings. The total reported buy value was $6.9 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.14% Add 6.8% 623,875 $17.62 M Q2 2026
0.03% New Buy 153,887 $4.35 M Q2 2026
0.00% New Buy 35,019 $988,937 Q2 2026
0.00% New Buy 15,739 $444,469 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form